| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.44 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |